A denoised multi-omics integration framework for cancer subtype classification and survival prediction.

artificial intelligence cancer subtype classification multi-omics integration omics-data denoising survival prediction

Journal

Briefings in bioinformatics
ISSN: 1477-4054
Titre abrégé: Brief Bioinform
Pays: England
ID NLM: 100912837

Informations de publication

Date de publication:
20 09 2023
Historique:
received: 25 04 2023
revised: 04 07 2023
accepted: 04 08 2023
medline: 25 9 2023
pubmed: 18 8 2023
entrez: 18 8 2023
Statut: ppublish

Résumé

The availability of high-throughput sequencing data creates opportunities to comprehensively understand human diseases as well as challenges to train machine learning models using such high dimensions of data. Here, we propose a denoised multi-omics integration framework, which contains a distribution-based feature denoising algorithm, Feature Selection with Distribution (FSD), for dimension reduction and a multi-omics integration framework, Attention Multi-Omics Integration (AttentionMOI) to predict cancer prognosis and identify cancer subtypes. We demonstrated that FSD improved model performance either using single omic data or multi-omics data in 15 The Cancer Genome Atlas Program (TCGA) cancers for survival prediction and kidney cancer subtype identification. And our integration framework AttentionMOI outperformed machine learning models and current multi-omics integration algorithms with high dimensions of features. Furthermore, FSD identified features that were associated to cancer prognosis and could be considered as biomarkers.

Identifiants

pubmed: 37594302
pii: 7245703
doi: 10.1093/bib/bbad304
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Jiali Pang (J)

Shanghai Artificial Intelligence Laboratory, Shanghai, China.

Bilin Liang (B)

Shanghai Artificial Intelligence Laboratory, Shanghai, China.

Ruifeng Ding (R)

Department of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China.

Qiujuan Yan (Q)

Shanghai Artificial Intelligence Laboratory, Shanghai, China.

Ruiyao Chen (R)

Shanghai Artificial Intelligence Laboratory, Shanghai, China.

Jie Xu (J)

Shanghai Artificial Intelligence Laboratory, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH